Global Angong Niuhuang Pill Market Research Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Angong Niuhuang Pill Market Research Report 2024
An effective first-aid medicine against fever or other more serious health problems. Except for treating high fever, the Niuhuang pill is also used for strokes, headaches, dizziness, epilepsy and nausea.
According to Mr Accuracy reports’s new survey, global Angong Niuhuang Pill market is projected to reach US$ million in 2034, increasing from US$ million in 2024, with the CAGR of % during the period of 2023 to 2034. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Angong Niuhuang Pill market research.
Key manufacturers engaged in the Angong Niuhuang Pill industry include Beijing TRT Group, GuangYuYuan Chinese Herbal Medicine Co.,Ltd., Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited, Mapakleung Co., Ltd, Jiuzhitang Co., Ltd., Wai Yuen Tong Medicine Co.,Ltd., Tianjin Zhongxin Pharmaceutical Group Corporation Limited, Hangzhou HU QING YU TANG Pharmaceutical Co., Ltd. and Shandong Hongjitang Co., Ltd., etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2024.
When refers to consumption region, % volume of Angong Niuhuang Pill were sold to North America, Europe and Asia Pacific in 2024. Moreover, China, plays a key role in the whole Angong Niuhuang Pill market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2024) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Angong Niuhuang Pill market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Beijing TRT Group
GuangYuYuan Chinese Herbal Medicine Co.,Ltd.
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited
Mapakleung Co., Ltd
Jiuzhitang Co., Ltd.
Wai Yuen Tong Medicine Co.,Ltd.
Tianjin Zhongxin Pharmaceutical Group Corporation Limited
Hangzhou HU QING YU TANG Pharmaceutical Co., Ltd.
Shandong Hongjitang Co., Ltd.
Sinopharm Group Fengliaoxing (Foshan) Pharmaceutical Co., Ltd.
Segment by Type
Natural Ingredients
Synthetic Ingredients
Stroke
Coma
Centric Fever
Viral Encephalitis
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Angong Niuhuang Pill report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source
According to Mr Accuracy reports’s new survey, global Angong Niuhuang Pill market is projected to reach US$ million in 2034, increasing from US$ million in 2024, with the CAGR of % during the period of 2023 to 2034. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Angong Niuhuang Pill market research.
Key manufacturers engaged in the Angong Niuhuang Pill industry include Beijing TRT Group, GuangYuYuan Chinese Herbal Medicine Co.,Ltd., Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited, Mapakleung Co., Ltd, Jiuzhitang Co., Ltd., Wai Yuen Tong Medicine Co.,Ltd., Tianjin Zhongxin Pharmaceutical Group Corporation Limited, Hangzhou HU QING YU TANG Pharmaceutical Co., Ltd. and Shandong Hongjitang Co., Ltd., etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2024.
When refers to consumption region, % volume of Angong Niuhuang Pill were sold to North America, Europe and Asia Pacific in 2024. Moreover, China, plays a key role in the whole Angong Niuhuang Pill market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2024) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Angong Niuhuang Pill market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Beijing TRT Group
GuangYuYuan Chinese Herbal Medicine Co.,Ltd.
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited
Mapakleung Co., Ltd
Jiuzhitang Co., Ltd.
Wai Yuen Tong Medicine Co.,Ltd.
Tianjin Zhongxin Pharmaceutical Group Corporation Limited
Hangzhou HU QING YU TANG Pharmaceutical Co., Ltd.
Shandong Hongjitang Co., Ltd.
Sinopharm Group Fengliaoxing (Foshan) Pharmaceutical Co., Ltd.
Segment by Type
Natural Ingredients
Synthetic Ingredients
Segment by Application
Stroke
Coma
Centric Fever
Viral Encephalitis
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Angong Niuhuang Pill report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source